Dr. Campbell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1501 N Campbell Ave
Tucson, AZ 85724Phone+1 520-874-3500
Education & Training
- Emory University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1971 - 1972
- Emory University School of MedicineResidency, Internal Medicine, 1968 - 1970
- Emory University School of MedicineClass of 1968
Certifications & Licensure
- AZ State Medical License 1977 - 2025
- GA State Medical License 1969 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 16 citationsLong-term safety of nebulized formoterol: Results of a twelve-month open-label clinical trial:James F. Donohue, Nicola A. Hanania, Charles Fogarty, Sammy C. Campbell, Mike Rinehart
Therapeutic Advances in Respiratory Disease. 2008-08-01 - 28 citationsCardiac safety of formoterol 12 μg twice daily in patients with chronic obstructive pulmonary diseaseSammy C. Campbell, Gerard J. Criner, Bernard E. Levine, Stuart J. Simon, Jonathan S. Smith
Pulmonary Pharmacology & Therapeutics. 2007-10-01 - 38 citationsFor COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base.Sammy C. Campbell
Archives of Internal Medicine. 1999-01-25
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: